Immunogen | IMGN - 販売および管理費



販売および管理費 変化する 日付
AbbVie USD 3.63B 54M 2026-06
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Amgen USD 1.72B 134M 2026-06
Astellas Pharma JPY 215.07B 19.63B 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Exelixis USD 147.63M 8.03M 2026-06
Halozyme Therapeutics USD 57M 10.71M 2026-06
Heron Therapeutics USD 23.74M 605K 2025-12
Intrexon USD 10.31M 41K 2024-06
Karyopharm Therapeutics USD 10.42M 861K 2026-03
MacroGenics USD 9.71M 1.77M 2026-03
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.14B 296M 2026-03
Pfizer USD 3.41B 496M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.49B 252M 2026-03